fluoxetine has been researched along with Agoraphobia in 12 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with DSM-III-R panic disorder were treated openly with fluoxetine, 20-40 mg daily." | 9.09 | Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. ( Ballenger, JC; Brawman-Mintzer, O; Emmanuel, NP; Lydiard, RB; Ware, MR, 1999) |
| "Ten patients with DSM-III-R panic disorder were treated openly with fluoxetine, 20-40 mg daily." | 5.09 | Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder. ( Ballenger, JC; Brawman-Mintzer, O; Emmanuel, NP; Lydiard, RB; Ware, MR, 1999) |
| "The main objective of this report was to identify patient characteristics that led psychiatrists in an academic anxiety disorders clinic to make a decision about intensive treatment of patients with panic disorder with agoraphobia (PDA) with cognitive-behavioral therapy (CBT) alone, CBT plus a high-potency benzodiazepine (CBT+BZ) or CBT combined with BZ and an antidepressant, fluoxetine (CBT+BZ+AD)." | 3.72 | Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices. ( Kolar, D; Latas, M; Linden, M; Starcevic, V; Uhlenhuth, EH, 2004) |
| "Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months." | 3.68 | Fluoxetine in panic disorder. ( Campeas, R; Davies, SO; Fairbanks, J; Hollander, E; Klein, DF; Liebowitz, MR; Schneier, FR, 1990) |
| "Fluoxetine, which has a long half-life, was more difficult to titrate." | 1.28 | Apathy and indifference in patients on fluvoxamine and fluoxetine. ( Hoehn-Saric, R; Lipsey, JR; McLeod, DR, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 7 (58.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Starcevic, V | 1 |
| Linden, M | 1 |
| Uhlenhuth, EH | 2 |
| Kolar, D | 1 |
| Latas, M | 1 |
| Pecknold, JC | 1 |
| Luthe, L | 1 |
| Iny, L | 1 |
| Ramdoyal, D | 1 |
| Larson, EW | 1 |
| Phillips, KA | 1 |
| McElroy, SL | 1 |
| Keck, PE | 1 |
| Pope, HG | 1 |
| Hudson, JI | 1 |
| Emmanuel, NP | 1 |
| Ware, MR | 1 |
| Brawman-Mintzer, O | 1 |
| Ballenger, JC | 1 |
| Lydiard, RB | 3 |
| Frank, E | 1 |
| Shear, MK | 1 |
| Rucci, P | 1 |
| Cyranowski, JM | 1 |
| Endicott, J | 1 |
| Fagiolini, A | 1 |
| Grochocinski, VJ | 1 |
| Houck, P | 1 |
| Kupfer, DJ | 1 |
| Maser, JD | 1 |
| Cassano, GB | 1 |
| Matuzas, W | 1 |
| Warner, TD | 1 |
| Paine, S | 1 |
| Pollack, MH | 1 |
| Solyom, L | 1 |
| Solyom, C | 1 |
| Ledwidge, B | 1 |
| Hoehn-Saric, R | 1 |
| Lipsey, JR | 1 |
| McLeod, DR | 1 |
| Schneier, FR | 1 |
| Liebowitz, MR | 2 |
| Davies, SO | 1 |
| Fairbanks, J | 1 |
| Hollander, E | 1 |
| Campeas, R | 1 |
| Klein, DF | 2 |
| Brady, K | 1 |
| Zarzar, M | 1 |
| Gorman, JM | 1 |
| Dillon, D | 1 |
| Fyer, AJ | 1 |
| Cohen, BS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Silymarin Treatment of Body Dysmorphic Disorder: A Double-Blind, Placebo-Controlled, Cross-Over Study[NCT02843451] | Phase 2 | 0 participants (Actual) | Interventional | 2016-10-31 | Withdrawn (stopped due to Focus on other studies) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 trials available for fluoxetine and Agoraphobia
| Article | Year |
|---|---|
Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study.
Topics: Adolescent; Adult; Agoraphobia; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Panic Dis | 1995 |
Once-weekly dosing of fluoxetine in the maintenance of remission in panic disorder.
Topics: Adult; Agoraphobia; Comorbidity; Drug Administration Schedule; Female; Fluoxetine; Humans; Middle Ag | 1999 |
Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression.
Topics: Adult; Agoraphobia; Ambulatory Care; Antidepressive Agents; Combined Modality Therapy; Comorbidity; | 2000 |
Do antidepressants selectively suppress spontaneous (unexpected) panic attacks? A replication.
Topics: Agoraphobia; Analysis of Variance; Data Interpretation, Statistical; Dose-Response Relationship, Dru | 2000 |
8 other studies available for fluoxetine and Agoraphobia
| Article | Year |
|---|---|
Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.
Topics: Adult; Agoraphobia; Anxiety; Benzodiazepines; Choice Behavior; Cognitive Behavioral Therapy; Combine | 2004 |
Migraine with typical aura associated with fluoxetine therapy: case report.
Topics: Agoraphobia; Fluoxetine; Functional Laterality; Humans; Male; Middle Aged; Migraine Disorders; Panic | 1993 |
Body dysmorphic disorder: 30 cases of imagined ugliness.
Topics: Adolescent; Adult; Age Factors; Aged; Agoraphobia; Anxiety Disorders; Body Image; Clomipramine; Delu | 1993 |
Fluoxetine in panic disorder.
Topics: Adult; Agoraphobia; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Follo | 1991 |
Apathy and indifference in patients on fluvoxamine and fluoxetine.
Topics: Adult; Agoraphobia; Antidepressive Agents; Anxiety Disorders; Arousal; Depressive Disorder; Dose-Res | 1990 |
Fluoxetine in panic disorder.
Topics: Adult; Agoraphobia; Anxiety Disorders; Benzodiazepines; Fear; Female; Fluoxetine; Humans; Male; Pani | 1990 |
Fluoxetine in panic disorder patients with imipramine-associated weight gain.
Topics: Adult; Agoraphobia; Depressive Disorder; Fear; Female; Fluoxetine; Humans; Imipramine; Middle Aged; | 1989 |
Antipanic drug effects during lactate infusion in lactate-refractory panic patients.
Topics: Adult; Agoraphobia; Alprazolam; Clonidine; Desipramine; Fear; Female; Fluoxetine; Humans; Imipramine | 1987 |